4th China BioPharma Convention-Antibody & Vaccine Focus 2014
Biotech drugs have entered the large-scale production stage worldwide. Following the pace, the State Council policy documents have listed the biopharmaceutical as a key development area. It’s expected in 2015 that the volume of China's biopharmaceutical market is expected to reach $100 billion, and antibody drug industry output value will exceed 40 billion. Meanwhile, by the end of 2013, China’s vaccine total production is more than 20 billion RMB, and has steadily grown at an average annual rate of 18%. As the strategic products which are critical to the revitalization of national development, vaccine industry development has been paid much emphasis and stimulated by government powerful policies.
More...